Välkommen tillbaka till Campusbokhandeln! Vi firar med inlämningskampanj: Lämna in din kurslitteratur – få 150 :- och chansen att vinna 1 000 :-. Läs mer här!
Controversial Statistical Issues in Clinical Trials | 1:a upplagan
- Danskt band, Engelska, 2020
- Författare: Shein-Chung Chow
- Betyg:
Skickas inom 7-22 vardagar
Fler utgåvor
-
Applied Meta-Analysis with R and Stata (2021)
1967 kr
-
Cure Models (2021)
995 kr
-
Real-World Evidence in Drug Development and Evaluation (2021)
1267 kr
-
Bayesian Analysis of Infectious Diseases (2021)
1189 kr
-
Medical Risk Prediction Models (2021)
2197 kr
-
Design and Analysis of Animal Studies in Pharmaceutical Development (2020)
567 kr
-
Randomized Phase II Cancer Clinical Trials (2020)
567 kr
-
Benefit-Risk Assessment in Pharmaceutical Research and Development (2020)
567 kr
-
Bayesian Methods in Epidemiology (2020)
567 kr
-
Sample Size Calculations for Clustered and Longitudinal Outcomes in Clinical Research (2020)
504 kr
-
Inference Principles for Biostatisticians (2020)
567 kr
-
Medical Product Safety Evaluation (2020)
567 kr
-
Measures of Interobserver Agreement and Reliability (2020)
567 kr
-
Confidence Intervals for Proportions and Related Measures of Effect Size (2020)
567 kr
-
Randomized Clinical Trials of Nonpharmacological Treatments (2020)
567 kr
-
Interval-Censored Time-to-Event Data (2020)
567 kr
-
Statistical Design and Analysis of Stability Studies (2020)
567 kr
-
Bayesian Methods for Measures of Agreement (2020)
567 kr
-
Clinical Trial Methodology (2020)
567 kr
-
Design and Analysis of Bridging Studies (2020)
567 kr
-
Design and Analysis of Non-Inferiority Trials (2020)
567 kr
-
Advanced Bayesian Methods for Medical Test Accuracy (2020)
567 kr
-
Bayesian Analysis Made Simple (2020)
567 kr
-
Quantitative Methods for HIV/AIDS Research (2020)
567 kr
Beskrivning
The book focuses on issues occurring at various stages of clinical research and development, including early-phase clinical development (such as bioavailability/bioequivalence), bench-to-bedside translational research, and late-phase clinical development. Numerous examples illustrate the impact of these issues on the evaluation of the safety and efficacy of the test treatment under investigation. The author also offers recommendations regarding possible resolutions of the problems.
Written by one of the preeminent experts in the field, this book provides a useful desk reference and state-of-the art examination of problematic issues in clinical trials for scientists in the pharmaceutical industry, medical/statistical reviewers in government regulatory agencies, and researchers and students in academia.
Produktinformation